Opexa Therapeutics says evaluating potential of stem cell platform Says working to secure additional resources to fund Phase IIb SPMS trial. Says evaluating T-cell platform to possibly advance in other development opportunities. Comments from slides that will be presented at the 15th Annual BIO CEO & Investor Conference.
News For OPXA From The Last 14 Days
Check below for free stories on OPXA the last two weeks.